FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296124562> ?p ?o ?g. }

• W4296124562 endingPage "109231" @default.
• W4296124562 startingPage "109231" @default.
• W4296124562 abstract "To explore the expression level, association with disease activity and clinical significance of hsa_circ_0008301 in the peripheral blood of patients with primary Sjögren's syndrome (pSS).We selected 70 pSS patients hospitalized under the Rheumatology service line at the General Hospital of Ningxia Medical University from September 2018 to June 2021 as the disease group, in which general data and clinical indicators were collected. Fifty-three patients with healthy physical examinations for the same period were selected as the healthy control group, and 32 patients with non-pSS rheumatic diseases were selected as the disease control group. We collected peripheral blood samples and used fluorescence quantitative PCR to detect the expression level of hsa_circ_0008301. In addition, we analyzed the association of the expression level of hsa_circ_0008301 with the clinical characteristics and disease activity of pSS patients. A receiver operating characteristic curve was used to evaluate the diagnosis and the disease activity value of hsa_circ_0008301 in patients with pSS. Meanwhile, we analyzed the differential expression of hsa_circ_0008301 in 24 pSS patients selected from the disease group before and after treatment.The relative expression of hsa_circ_0008301 in the peripheral blood of pSS patients was significantly higher than that in the control groups including healthy control group and disease control group. The expression level of hsa_circ_0008301 was high in pSS patients with a course of disease ≥ 10 years, fatigue symptoms, platelets < 100*10^9/L, erythrocyte sedimentation rate ≥ 50 mm/h, immunoglobulin IgG > 16 g/L, complement C3 < 0.9 g/L, ESSDAI score ≥ 5 and positively correlated with the above groups. Furthermore, ROC analysis showed that hsa_circ_0008301 was statistically significant between pSS patients and healthy controls. We selected patients from the disease group before and after treatment and showed that the expression level of hsa_circ_0008301 decreased significantly after treatment, compared with before. The area under the curve (AUC) was 0.825 (95% CI: 0.754 ∼ 0.897; P < 0.0001). The AUC of hsa_circ_0008301 in pSS patients and the disease control group was 0.673 (95% CI: 0.563 ∼ 0.782; P = 0.005), the sensitivity was 40.00%, the specificity was 93.70%, the optimal truncation value was > 0.0420, and the maximum Youden index was 0.337. In addition, ROC analysis revealed that hsa_circ_0008301 was statistically significant between disease-active patients and stable patients. The AUC value was 0.681 (95% CI: 0.553 ∼ 0.809; P = 0.010), the sensitivity was 65.90%, the specificity was 72.40%, the optimal truncation value was > 0.0285, and the maximum Youden index was 0.383. ROC analysis indicated that hsa_circ_0008301 has some value in the diagnosis and disease activity of patients with pSS. Comparison of 24 pSS patients selected from the disease group before and after treatment showed that the expression level of hsa_circ_0008301 decreased significantly after treatment compared with before treatment (Z = - 4.257, P < 0.0001). ROC analysis indicated that hsa_circ_0008301 has some value in the diagnosis and disease activity of patients with pSS.Hsa_circ_0008301 is expressed in higher levels in the peripheral blood of patients with pSS, which is related to the disease activity. It may be involved in the occurrence and development of pSS and may have a potential biomarker for the disease." @default.
• W4296124562 created "2022-09-17" @default.
• W4296124562 creator A5008575732 @default.
• W4296124562 creator A5015934351 @default.
• W4296124562 creator A5016250956 @default.
• W4296124562 creator A5029667848 @default.
• W4296124562 creator A5032412994 @default.
• W4296124562 creator A5050613147 @default.
• W4296124562 creator A5060917619 @default.
• W4296124562 creator A5063880073 @default.
• W4296124562 creator A5080041548 @default.
• W4296124562 creator A5084344063 @default.
• W4296124562 creator A5091819559 @default.
• W4296124562 date "2022-11-01" @default.
• W4296124562 modified "2023-10-15" @default.
• W4296124562 title "Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome" @default.
• W4296124562 cites W1637475772 @default.
• W4296124562 cites W1967834717 @default.
• W4296124562 cites W1995586746 @default.
• W4296124562 cites W2017883909 @default.
• W4296124562 cites W2018967405 @default.
• W4296124562 cites W2026548655 @default.
• W4296124562 cites W2038051564 @default.
• W4296124562 cites W2068733429 @default.
• W4296124562 cites W2097181703 @default.
• W4296124562 cites W2128952811 @default.
• W4296124562 cites W2138474497 @default.
• W4296124562 cites W2147806662 @default.
• W4296124562 cites W2151882239 @default.
• W4296124562 cites W2164096595 @default.
• W4296124562 cites W2167385753 @default.
• W4296124562 cites W2168772512 @default.
• W4296124562 cites W2302185643 @default.
• W4296124562 cites W2379604527 @default.
• W4296124562 cites W2757694113 @default.
• W4296124562 cites W2797901643 @default.
• W4296124562 cites W2900664122 @default.
• W4296124562 cites W2944290456 @default.
• W4296124562 cites W2946789782 @default.
• W4296124562 cites W2950221417 @default.
• W4296124562 cites W2954902957 @default.
• W4296124562 cites W2966041078 @default.
• W4296124562 cites W2969194457 @default.
• W4296124562 cites W2991863184 @default.
• W4296124562 cites W3000614820 @default.
• W4296124562 cites W3014323160 @default.
• W4296124562 cites W3022289262 @default.
• W4296124562 cites W3042664378 @default.
• W4296124562 cites W3094819482 @default.
• W4296124562 cites W3095020254 @default.
• W4296124562 cites W3097124900 @default.
• W4296124562 cites W3129382234 @default.
• W4296124562 cites W3160396928 @default.
• W4296124562 cites W3190095789 @default.
• W4296124562 cites W3206383863 @default.
• W4296124562 cites W4211082175 @default.
• W4296124562 doi "https://doi.org/10.1016/j.intimp.2022.109231" @default.
• W4296124562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36113315" @default.
• W4296124562 hasPublicationYear "2022" @default.
• W4296124562 type Work @default.
• W4296124562 citedByCount "1" @default.
• W4296124562 countsByYear W42961245622023 @default.
• W4296124562 crossrefType "journal-article" @default.
• W4296124562 hasAuthorship W4296124562A5008575732 @default.
• W4296124562 hasAuthorship W4296124562A5015934351 @default.
• W4296124562 hasAuthorship W4296124562A5016250956 @default.
• W4296124562 hasAuthorship W4296124562A5029667848 @default.
• W4296124562 hasAuthorship W4296124562A5032412994 @default.
• W4296124562 hasAuthorship W4296124562A5050613147 @default.
• W4296124562 hasAuthorship W4296124562A5060917619 @default.
• W4296124562 hasAuthorship W4296124562A5063880073 @default.
• W4296124562 hasAuthorship W4296124562A5080041548 @default.
• W4296124562 hasAuthorship W4296124562A5084344063 @default.
• W4296124562 hasAuthorship W4296124562A5091819559 @default.
• W4296124562 hasBestOaLocation W42961245621 @default.
• W4296124562 hasConcept C126322002 @default.
• W4296124562 hasConcept C146304588 @default.
• W4296124562 hasConcept C159654299 @default.
• W4296124562 hasConcept C1621761 @default.
• W4296124562 hasConcept C185592680 @default.
• W4296124562 hasConcept C198451711 @default.
• W4296124562 hasConcept C203014093 @default.
• W4296124562 hasConcept C2778143017 @default.
• W4296124562 hasConcept C2779075594 @default.
• W4296124562 hasConcept C2779134260 @default.
• W4296124562 hasConcept C2781197716 @default.
• W4296124562 hasConcept C3017910909 @default.
• W4296124562 hasConcept C55493867 @default.
• W4296124562 hasConcept C58471807 @default.
• W4296124562 hasConcept C63363279 @default.
• W4296124562 hasConcept C71924100 @default.
• W4296124562 hasConcept C90924648 @default.
• W4296124562 hasConceptScore W4296124562C126322002 @default.
• W4296124562 hasConceptScore W4296124562C146304588 @default.
• W4296124562 hasConceptScore W4296124562C159654299 @default.
• W4296124562 hasConceptScore W4296124562C1621761 @default.
• W4296124562 hasConceptScore W4296124562C185592680 @default.
• W4296124562 hasConceptScore W4296124562C198451711 @default.

• next